NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
45 hedge funds and large institutions have $17.1M invested in Nymox Pharmaceutical Corp in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
80% less call options, than puts
Call options by funds: $842K | Put options by funds: $4.16M
Holders
45
Holding in Top 10
–
Calls
$842K
Puts
$4.16M
Top Buyers
| 1 | +$5.14M | |
| 2 | +$1.32M | |
| 3 | +$847K | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$329K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$325K |
Top Sellers
| 1 | -$753K | |
| 2 | -$167K | |
| 3 | -$124K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$84K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$51K |